These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10567952)

  • 1. A pharmacokinetic/pharmacodynamic approach to predict the cumulative cortisol suppression of inhaled corticosteroids.
    Meibohm B; Hochhaus G; Möllmann H; Barth J; Wagner M; Krieg M; Stöckmann R; Derendorf H
    J Pharmacokinet Biopharm; 1999 Apr; 27(2):127-47. PubMed ID: 10567952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized therapeutic ratio of inhaled corticosteroids using retrometabolism.
    Derendorf H; Hochhaus G; Krishnaswami S; Meibohm B; Möllmann H
    Pharmazie; 2000 Mar; 55(3):223-7. PubMed ID: 10756545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An interactive algorithm for the assessment of cumulative cortisol suppression during inhaled corticosteroid therapy.
    Krishnaswami S; Hochhaus G; Derendorf H
    AAPS PharmSci; 2000; 2(3):E22. PubMed ID: 11741238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dependency of cortisol suppression on the administration time of inhaled corticosteroids.
    Meibohm B; Hochhaus G; Rohatagi S; Möllmann H; Barth J; Wagner M; Krieg M; Stöckmann R; Derendorf H
    J Clin Pharmacol; 1997 Aug; 37(8):704-10. PubMed ID: 9378842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
    Möllmann H; Wagner M; Krishnaswami S; Dimova H; Tang Y; Falcoz C; Daley-Yates PT; Krieg M; Stöckmann R; Barth J; Lawlor C; Möllmann AC; Derendorf H; Hochhaus G
    J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model.
    Daley-Yates PT; Richards DH
    Clin Ther; 2004 Nov; 26(11):1905-19. PubMed ID: 15639702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler.
    Grahnén A; Jansson B; Brundin RM; Ling-Andersson A; Lönnebo A; Johansson M; Eckernäs SA
    Eur J Clin Pharmacol; 1997; 52(4):261-7. PubMed ID: 9248762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids.
    Wilson AM; Lipworth BJ
    Thorax; 1999 Jan; 54(1):20-6. PubMed ID: 10343626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration.
    Möllmann H; Wagner M; Meibohm B; Hochhaus G; Barth J; Stöckmann R; Krieg M; Weisser H; Falcoz C; Derendorf H
    Eur J Clin Pharmacol; 1998 Feb; 53(6):459-67. PubMed ID: 9551705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new solution-based intranasal triamcinolone acetonide formulation in patients with perennial allergic rhinitis: how does the pharmacokinetic/pharmacodynamic profile for cortisol suppression compare with an aqueous suspension-based formulation?
    Hochhaus G; González MA; Dockhorn RJ; Shilstone J; Karafilidis J
    J Clin Pharmacol; 2002 Jun; 42(6):662-9. PubMed ID: 12043955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety.
    Derendorf H
    Respir Med; 1997 Nov; 91 Suppl A():22-8. PubMed ID: 9474364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the administration time effect on the cumulative cortisol suppression and cumulative lymphocytes suppression for once-daily inhaled corticosteroids: a population modeling/simulation approach.
    Wu K; Goyal N; Stark JG; Hochhaus G
    J Clin Pharmacol; 2008 Sep; 48(9):1069-80. PubMed ID: 18728243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma.
    Xu J; Nave R; Lahu G; Derom E; Derendorf H
    J Clin Pharmacol; 2010 Oct; 50(10):1118-27. PubMed ID: 20150524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions.
    Kirby S; Falcoz C; Daniel MJ; Milleri S; Squassante L; Ziviani L; Ventresca GP
    Eur J Clin Pharmacol; 2001; 56(11):781-91. PubMed ID: 11294367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the best marker for inhaled corticosteroid safety?
    Derendorf H; Hochhaus G
    Allergy Asthma Proc; 2005; 26(2):89-93. PubMed ID: 15971465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers.
    Grahnén A; Eckernäs SA; Brundin RM; Ling-Andersson A
    Br J Clin Pharmacol; 1994 Dec; 38(6):521-5. PubMed ID: 7888290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers.
    Wilson AM; Clark DJ; McFarlane L; Lipworth BJ
    Eur J Clin Pharmacol; 1997; 53(1):33-7. PubMed ID: 9349927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
    Clark DJ; Lipworth BJ
    Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal suppression by inhaled corticosteroids in patients with asthma: A systematic review and quantitative analysis.
    Kowalski ML; Wojciechowski P; Dziewonska M; Rys P
    Allergy Asthma Proc; 2016; 37(1):9-17. PubMed ID: 26831841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
    Lipworth BJ; Clark DJ; McFarlane LC
    Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.